http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Pauses (and other prosodic features) in Simultaneous Interpreting
( Barbara Ahrens ) 한국통역번역학회 2007 FORUM Vol.5 No.1
L`interpretation simultanee est une forme de communication orale specifique qui se distingue par des elements prosodiques tels que les intonations ou les pauses, elements-cle tant pour le texte d`origine que pour le texte-cible. Les pauses figurent parmi les phenomenes durationnels destines a segmenter le continuum acoustique en unites d`information. De plus, elles revelent les processus cognitifs qui sont a la base de toute production de parole. Le present article analyse le taux de parole et la structure des pauses dans un corpus authentique de prestations d`interpretation simultanee dans le couple linguistique anglais - allemand tout en etudiant leurs fonctions et leurs interactions avec d`autres phenomenes prosodiques.
( Barbara Ahrens ) 한국통역번역학회 2005 FORUM Vol.3 No.2
Cet article porte sur la technique de prise de notes lors de l`interpretation consecutive tout en abordant les objectifs du cours de prise de notes, qui ne se limite pas simplement a faire connaitre des symboles et des abreviations. Cette discussion est suivie d`une presentation et d`une comparaison des systemes de prise de notes de Rozan (1956) et de Matyssek (1989) et de leurs principes generaux, afin de demontrer que ces deux ecoles ? classiques ? ont nombre de points communs bien qu`elles soient frequemment considerees comme etant tres differentes.
Christian Mölleken,Maike Ahrens,Anders Schlosser,Julia Dietz,Martin Eisenacher,Helmut E. Meyer,Wolff Schmiegel,Uffe Holmskov,Christoph Sarrazin,Grith Lykke Sorensen,Barbara Sitek,Thilo Bracht 대한간학회 2019 Clinical and Molecular Hepatology(대한간학회지) Vol.25 No.1
Background/Aims: An estimated 80 million people worldwide are infected with viremic hepatitis C virus (HCV). Even after eradication of HCV with direct acting antivirals (DAAs), hepatic fibrosis remains a risk factor for hepatocarcinogenesis. Recently, we confirmed the applicability of microfibrillar-associated protein 4 (MFAP4) as a serum biomarker for the assessment of hepatic fibrosis. The aim of the present study was to assess the usefulness of MFAP4 as a biomarker of liver fibrosis after HCV eliminating therapy with DAAs. Methods: MFAP4 was measured using an immunoassay in 50 hepatitis C patients at baseline (BL), the end-of-therapy (EoT), and the 12-week follow-up (FU) visit. Changes in MFAP4 from BL to FU and their association with laboratory parameters including alanine aminotransferase (ALT), aspartate aminotransferase (AST), platelets, the AST to platelet ratio index (APRI), fibrosis-4 score (FIB-4), and albumin were analyzed. Results: MFAP4 serum levels were representative of the severity of hepatic fibrosis at BL and correlated well with laboratory parameters, especially APRI (Spearman correlation, R²=0.80). Laboratory parameters decreased significantly from BL to EoT. MFAP4 serum levels were found to decrease from BL and EoT to FU with high statistical significance (Wilcoxon P<0.001 for both). Conclusions: Our findings indicate that viral eradication resulted in reduced MFAP4 serum levels, presumably representing a decrease in hepatic fibrogenesis or fibrosis. Hence, MFAP4 may be a useful tool for risk assessment in hepatitis C patients with advanced fibrosis after eradication of the virus.